Skip to main content
| News

Genedata accelerating drug development

16.07.2020

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Genedata has developed a platform for managing data from biopharmaceutical research. This platform also allows data to be brought together from different sources and then processed. The announced collaboration with international pharmaceutical and laboratory equipment supplier Thermo Fisher will now enable the direct integration of Thermo Fisher’s robotics and automation platforms with the Genedata Biopharma Platform, as was reported in a Genedata press release.

The two companies will consequently be able to offer scientists a centralized platform that delivers automation systems for sample handling, lab operations and testing and enables them to digitally trace all results for every sample of imported raw instrument data. This will accelerate the discovery and development of next-generation biotherapeutics, the Basel IT company says. Integrating the two platforms gives researchers the power to make data-based decisions and uncover insights not possible before, explained Hansjoerg Hass, Senior Director Lab Automation at Thermo Fisher.

The integration includes both laboratory instruments and software from Thermo Fisher. Both companies are implementing interfaces for the seamless integration of all areas of the two platforms. Genedata has extensive experience in projects of this kind, with the Basel company’s IT solutions having been used by other major players to automate complex laboratory workflows with lab equipment, as Othmar Pfannes, CEO of Genedata, outlines.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
1 2 3 59

Do you have a question? We'd like to hear from you.